Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.17
+0.08 (1.13%)
Nov 5, 2024, 10:57 AM EST - Market open

Kezar Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-98.57-101.87-68.24-54.63-41.74-35.09
Upgrade
Depreciation & Amortization
1.081.071.021.511.541.3
Upgrade
Other Amortization
0.250.240.210.09--
Upgrade
Asset Writedown & Restructuring Costs
4.462.91----
Upgrade
Loss (Gain) From Sale of Investments
-6.2-6.83-1.41.770.32-0.98
Upgrade
Stock-Based Compensation
16.3718.1414.017.64.944.01
Upgrade
Other Operating Activities
000.01---
Upgrade
Change in Accounts Payable
0.796.351.811.220.312.21
Upgrade
Change in Other Net Operating Assets
2.74-1.64-6.270.01-2.32-1.33
Upgrade
Operating Cash Flow
-79.08-81.65-58.85-42.44-36.95-29.88
Upgrade
Capital Expenditures
-0.14-1.81-1.58-0.32-0.19-0.61
Upgrade
Sale of Property, Plant & Equipment
0.010.01----
Upgrade
Investment in Securities
79.2177.85-89.81-28.13-56.321.03
Upgrade
Investing Cash Flow
79.0876.05-91.39-28.44-56.520.42
Upgrade
Long-Term Debt Issued
---9.53--
Upgrade
Net Debt Issued (Repaid)
---9.53--
Upgrade
Issuance of Common Stock
0.160.64127.86103.0599.640.27
Upgrade
Financing Cash Flow
0.160.64127.86112.5999.640.27
Upgrade
Foreign Exchange Rate Adjustments
0.01-0-0.05-0.050.08-0.05
Upgrade
Net Cash Flow
0.17-4.96-22.4341.656.28-9.23
Upgrade
Free Cash Flow
-79.22-83.46-60.42-42.75-37.14-30.48
Upgrade
Free Cash Flow Margin
-1131.64%-1192.21%----
Upgrade
Free Cash Flow Per Share
-10.89-11.50-8.97-8.10-8.44-15.97
Upgrade
Cash Interest Paid
1.351.320.970.07--
Upgrade
Levered Free Cash Flow
-41.5-39.23-36-22.7-21.69-17.42
Upgrade
Unlevered Free Cash Flow
-40.75-38.5-35.47-22.69-21.69-17.42
Upgrade
Change in Net Working Capital
-4.15-9.884.44-2.681.14-1.21
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.